Cannabis in Inflammatory Bowel Diseases: from Anecdotal Use to Medicalization?

被引：0
作者：
Naftali, Timna [1 ,2 ]
Konikoff, Fred M. [1 ,2 ]
机构：
[1] Meir Med Ctr, Inst Gastroenterol & Hepatol, Kefar Sava, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
来源：
ISRAEL MEDICAL ASSOCIATION JOURNAL | 2017年 / 19卷 / 02期
关键词：
cannabis; inflammatory bowel disease (IBD); Crohn's disease; ulcerative colitis; Delta 9tetrahydrocannabinol (THC); cannabidiol (CBD); CROHNS-DISEASE; COLITIS; CELLS; DRUG;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：95 / 97
页数：3
相关论文
共 22 条
[1]   Environmental risk factors for inflammatory bowel diseases: Evidence based literature review [J].
Abegunde, Ayokunle T. ;
Muhammad, Bashir H. ;
Bhatti, Owais ;
Ali, Tauseef .
WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (27) :6296-6317
[2]   Clinical, serological and genetic predictors of inflammatory bowel disease course [J].
Beaugerie, Laurent ;
Sokol, Harry .
WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (29) :3806-3813
[3]   Neuroimmunomodulation in the Gut: Focus on Inflammatory Bowel Disease [J].
Bernardazzi, Claudio ;
Pego, Beatriz ;
de Souza, Heitor Siffert P. .
MEDIATORS OF INFLAMMATION, 2016, 2016
[4]   Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease [J].
Borrelli, Francesca ;
Fasolino, Ines ;
Romano, Barbara ;
Capasso, Raffaele ;
Maiello, Francesco ;
Coppola, Diana ;
Orlando, Pierangelo ;
Battista, Giovanni ;
Pagano, Ester ;
Di Marzo, Vincenzo ;
Izzo, Angelo A. .
BIOCHEMICAL PHARMACOLOGY, 2013, 85 (09) :1306-1316
[5]   Factors affecting outcomes in Crohn's disease over 15 years [J].
Cosnes, Jacques ;
Bourrier, Anne ;
Nion-Larmurier, Isabelle ;
Sokol, Harry ;
Beaugerie, Laurent ;
Seksik, Philippe .
GUT, 2012, 61 (08) :1140-1145
[6]   Cannabinoids ablate release of TNFα in rat microglial cells stimulated with lypopolysaccharide [J].
Facchinetti, F ;
Del Giudice, E ;
Furegato, S ;
Passarotto, M ;
Leon, A .
GLIA, 2003, 41 (02) :161-168
[7]   The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease [J].
Hasenoehrl, C. ;
Taschler, U. ;
Storr, M. ;
Schicho, R. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 28 (12) :1765-1780
[8]  
Hirsch J, 2016, J CROHNS COLITIS S1, V10, P543
[9]   Cannabinoids and the gut: New developments and emerging concepts [J].
Izzo, Angelo A. ;
Sharkey, Keith A. .
PHARMACOLOGY & THERAPEUTICS, 2010, 126 (01) :21-38
[10]   The effects of Δ9-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis [J].
Jamontt, J. M. ;
Molleman, A. ;
Pertwee, R. G. ;
Parsons, M. E. .
BRITISH JOURNAL OF PHARMACOLOGY, 2010, 160 (03) :712-723
123